High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab

Influenza vaccination can be less effective in patients treated with immunosuppressive therapy. However, little is known about the effects of ustekinumab; an anti-IL-12/23 agent used to treat Crohn’s disease (CD), on vaccination response. In this prospective study, we assessed immune responses to se...

Descripción completa

Detalles Bibliográficos

Autores principales:	Laura Doornekamp, Rogier L. Goetgebuer, Katharina S. Schmitz, Marco Goeijenbier, C. Janneke van der Woude, Ron Fouchier, Eric C.M. van Gorp, Annemarie C. de Vries
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2020-08-01
Colección:	Vaccines
Materias:	ustekinumab influenza vaccine Crohn’s disease
Acceso en línea:	https://www.mdpi.com/2076-393X/8/3/455
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!